GPR15L



GPR15L

M1MM1R2RR2L3LL3L4LL4V5VV5L6LL6S7SS7S8SS8L9LL9L10LL10C11CC11I12II12L13LL13L14LL14L15LL15C16CC16F17FF17S18SS18I19II19F20FF20S21SS21T22TT22E23EE23G24GG24K25KK25R26RR26R27RR27P28PP28A29AA29K30KK30A31AA31W32WW32S33SS33G34GG34R35RR35R36RR36T37TT37R38RR38L39LL39C40CC40C41CC41H42HH42R43RR43V44VV44P45PP45S46SS46P47PP47... and 34 more residue(s)...... and 34 more residue(s)

SMILES None
InChIKey MKYBCIBFBPPBKT-QSWODBGPSA-N
Sequence MRLLVLSSLLCILLLCFSIFSTEGKRRPAKAWSGRRTRLCCHRVPSPNSTNLKGHHVRLCKPCKLEPEPRLWVVPGALPQV

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

GPR15L

M1MM1R2RR2L3LL3L4LL4V5VV5L6LL6S7SS7S8SS8L9LL9L10LL10C11CC11I12II12L13LL13L14LL14L15LL15C16CC16F17FF17S18SS18I19II19F20FF20S21SS21T22TT22E23EE23G24GG24K25KK25R26RR26R27RR27P28PP28A29AA29K30KK30A31AA31W32WW32S33SS33G34GG34R35RR35R36RR36T37TT37R38RR38L39LL39C40CC40C41CC41H42HH42R43RR43V44VV44P45PP45S46SS46P47PP47... and 34 more residue(s)...... and 34 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.